Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Blanchet

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Clinical Pharmacokinetics|August 11, 2018
Clinical Pharmacokinetics and Pharmacodynamics of DabrafenibAlicja Puszkiel, Gaëlle Noé, Audrey Bellesoeur, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 9, 2020
Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometryDavid Balakirouchenane, Nihel Khoudour, Sarah Guégan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2009
Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinomaBenoit Blanchet, Monika Hurtova, Françoise Roudot-Thoraval, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a reviewPascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2011
A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasmaLionel Faivre, Charline Gomo, Olivier Mir, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 3, 2023
LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's SyndromeDavid Balakirouchenane, Axelle Vasseur, Fidéline Bonnet-Serrano, et al.
Bulletin Du Cancer|October 13, 2018
[Issues of oral targeted therapies in daily clinical practice: 5th edition of the congress of pharmacology of anticancer drugs]Sonia Zaibet, Charles Vauchier, Nihel Khoudour, et al.
Plos One|June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinomaOlivier Mir, Romain Coriat, Benoit Blanchet, et al.
Pharmacological Research|July 6, 2016
Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patientsAlicja Puszkiel, Mélanie White-Koning, Nicolas Dupin, et al.
Cancers|October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant MelanomaNora Isberner, Anja Gesierich, David Balakirouchenane, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|August 11, 2018
Clinical Pharmacokinetics and Pharmacodynamics of DabrafenibAlicja Puszkiel, Gaëlle Noé, Audrey Bellesoeur, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 9, 2020
Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometryDavid Balakirouchenane, Nihel Khoudour, Sarah Guégan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2009
Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinomaBenoit Blanchet, Monika Hurtova, Françoise Roudot-Thoraval, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a reviewPascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2011
A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasmaLionel Faivre, Charline Gomo, Olivier Mir, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 3, 2023
LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's SyndromeDavid Balakirouchenane, Axelle Vasseur, Fidéline Bonnet-Serrano, et al.
Bulletin Du Cancer|October 13, 2018
[Issues of oral targeted therapies in daily clinical practice: 5th edition of the congress of pharmacology of anticancer drugs]Sonia Zaibet, Charles Vauchier, Nihel Khoudour, et al.
Plos One|June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinomaOlivier Mir, Romain Coriat, Benoit Blanchet, et al.
Pharmacological Research|July 6, 2016
Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patientsAlicja Puszkiel, Mélanie White-Koning, Nicolas Dupin, et al.
Cancers|October 14, 2022
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant MelanomaNora Isberner, Anja Gesierich, David Balakirouchenane, et al.
Pageof 11